Stoke Therapeutics plans to launch a Phase 3 study this year to evaluate zorevunersen, a potential disease-modifying therapy for…
Articles by Steve Bryson, PhD
Children with genetic causes of epilepsy, including Dravet syndrome, were more than five times more likely to have fewer…
The newly created DANCE checklist, to be completed by caregivers, may help diagnose additional conditions that often occur alongside…
Treatment with add-on Diacomit (stiripentol) rapidly reduced seizure frequency and extended seizure-free periods in children with Dravet syndrome,…
New treatment approaches, such as gene therapies, that aim to restore the activity of SCN1A, the gene often defective…
Recurrent seizures in a man with Dravet syndrome and high body temperature were managed by treating the recurrent infections…
Levodopa, the standard treatment for motor symptoms associated with Parkinson’s disease, improved walking abilities in people with…
Fintepla (fenfluramine) eased brain inflammation, protected nerve cells from damage and death, and extended survival in a mouse model…
STK-001, an investigational treatment for children and adolescents with Dravet syndrome, markedly reduced seizure frequency and improved cognition and…
Nighttime monitoring devices are used by most Dravet syndrome caregivers — at least 75% — to detect seizures and…